Skip to content
July 2, 2026
  • With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
  • Debunked Episode 28: A Little More Transparency, A Little More Action
  • Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
  • Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data

Medical Article

Newsletter
Random News
Headlines
  • With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs

    2 hours ago
  • Debunked Episode 28: A Little More Transparency, A Little More Action

    5 hours ago
  • Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It

    7 hours ago
  • Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data

    7 hours ago
  • Hantavirus Is the Warning Signal America Should Not Ignore

    7 hours ago
  • What Happens When AI Stops Answering and Starts Handling Healthcare Tasks?

    8 hours ago
  • Home
  • What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape
  • Medicine

What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape

2 months ago01 mins

The success of Pluvicto has created a new challenge in prostate cancer, one the field has not yet fully named or defined.

The post What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape appeared first on MedCity News.

Post navigation

Previous: Healthcare Doesn’t Need More Companies Managing Unnecessary Costs – It Needs a System Designed to Eliminate Them
Next: Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs

2 hours ago 0

Debunked Episode 28: A Little More Transparency, A Little More Action

5 hours ago 0

Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It

7 hours ago 0

Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data

7 hours ago 0

Recent Posts

  • With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
  • Debunked Episode 28: A Little More Transparency, A Little More Action
  • Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
  • Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data
  • Hantavirus Is the Warning Signal America Should Not Ignore

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.